Company intelligence / Profile preview

Winslow Management

Minneapolis, Minnesota, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Winslow Capital Management is a prominent growth equity investment firm that manages assets for institutional and individual investors. While not a biotechnology company itself, the firm maintains a significant focus on the healthcare and life sciences sectors through its large-cap growth strategies. Winslow Capital frequently invests in major pharmaceutical, biotechnology, and medical technology companies, conducting deep fundamental research to identify industry leaders with sustainable growth profiles. The firm operates as an independent investment franchise under the umbrella of Nuveen, a TIAA company.

Industry: Investors

Beyond the preview

Go deeper on Winslow Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Winslow Management.

Explore the full profile